• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断2型糖尿病患者循环微颗粒的蛋白质组学特征

Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

作者信息

Xu Min-Dan, Wu Xian-Zheng, Zhou Yun, Xue Ying, Zhang Ke-Qin

机构信息

Department of Endocrinology and Metabolism, Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, China.

Department of Emergency, Shanghai Tongji Hospital, Tongji University School of Medicine Shanghai, China.

出版信息

Am J Transl Res. 2016 Jan 15;8(1):209-20. eCollection 2016.

PMID:27069554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4759430/
Abstract

OBJECTIVE

This study aimed to evaluate the proteomic characteristics of plasma microparticles (MPs) from patients with newly diagnosed type 2 diabetes (T2DM).

METHODS

The subjects comprised eight male T2DM patients recruited between December 2013 and March 2014, as well as eight age and sex-matched healthy controls enrolled during the same period. Plasma microparticles (MPs) were extracted from the blood of each subject, and subjected to proteomics analysis using label-free methods. Bioinformatic analyses were performed using specialized software.

RESULTS

3,148 unique peptides and 496 proteins were identified, among these, 46 proteins were differentially expressed between the two groups. Among these 46 candidates, 20 proteins had higher expression in T2DM group compared with the control group, whereas 3 proteins displayed lower expression. There were 17 proteins only detected in T2DM group, and 6 proteins only detected in the control group. Gene ontology (GO) analysis revealed significant differences between the two groups in some functional nodes, including neutrophil accumulation, chemokine production, platelet activation, and blood coagulation. Pathway analysis showed that proteins involved in platelet activation, cell adhesion, focal adhesion, and extracellular matrix-receptor interaction were differentially expressed between the 2 groups. Network analysis indicated that ubiquitin was the protein with the highest degree of connectivity.

CONCLUSIONS

Blood MPs from T2DM patients are enriched in proteins involved in platelet activation, cell adhesion, and inflammation. Therefore, MPs in T2DM patients might be associated with hypercoagulable state in diabetic patients and the development of diabetic complications.

摘要

目的

本研究旨在评估新诊断的2型糖尿病(T2DM)患者血浆微颗粒(MPs)的蛋白质组学特征。

方法

研究对象包括2013年12月至2014年3月招募的8名男性T2DM患者,以及同期纳入的8名年龄和性别匹配的健康对照。从每个受试者的血液中提取血浆微颗粒(MPs),并使用无标记方法进行蛋白质组学分析。使用专门软件进行生物信息学分析。

结果

共鉴定出3148种独特肽段和496种蛋白质,其中46种蛋白质在两组之间存在差异表达。在这46种候选蛋白中,与对照组相比,20种蛋白在T2DM组中表达较高,而3种蛋白表达较低。有17种蛋白仅在T2DM组中检测到,6种蛋白仅在对照组中检测到。基因本体(GO)分析显示两组在一些功能节点上存在显著差异,包括中性粒细胞聚集、趋化因子产生、血小板活化和血液凝固。通路分析表明,参与血小板活化、细胞粘附、粘着斑和细胞外基质-受体相互作用的蛋白质在两组之间存在差异表达。网络分析表明泛素是连接度最高的蛋白质。

结论

T2DM患者的血液MPs富含参与血小板活化、细胞粘附和炎症的蛋白质。因此,T2DM患者的MPs可能与糖尿病患者的高凝状态及糖尿病并发症的发生有关。

相似文献

1
Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.新诊断2型糖尿病患者循环微颗粒的蛋白质组学特征
Am J Transl Res. 2016 Jan 15;8(1):209-20. eCollection 2016.
2
Involvement of microparticles in diabetic vascular complications.微粒体在糖尿病血管并发症中的作用。
Thromb Haemost. 2011 Aug;106(2):310-21. doi: 10.1160/TH10-11-0712. Epub 2011 Jun 28.
3
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.不同糖耐量患者循环微颗粒的水平和特征。
Cardiovasc Diabetol. 2017 Sep 19;16(1):118. doi: 10.1186/s12933-017-0600-0.
4
The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.患有无症状动脉粥样硬化的糖尿病患者循环微颗粒的模式
Acta Clin Belg. 2016 Feb;71(1):38-45. doi: 10.1080/17843286.2015.1110894. Epub 2016 Feb 3.
5
Type 2 diabetes and older age contribute to elevated plasma microparticle concentrations independent of chronic stroke.2型糖尿病和老年状态会导致血浆微粒浓度升高,这与慢性中风无关。
Exp Physiol. 2018 Nov;103(11):1560-1570. doi: 10.1113/EP087116. Epub 2018 Sep 2.
6
Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research.循环微颗粒水平在糖尿病肾病患者中升高:一项病例对照研究。
Clin Chim Acta. 2018 Apr;479:48-55. doi: 10.1016/j.cca.2017.12.048. Epub 2018 Jan 3.
7
Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis.2型糖尿病患者的细胞衍生微粒:系统评价与荟萃分析
Cell Physiol Biochem. 2016;39(6):2439-2450. doi: 10.1159/000452512. Epub 2016 Nov 11.
8
iTRAQ and PRM-based quantitative proteomics in T2DM-susceptible and -tolerant models of Bama mini-pig.基于 iTRAQ 和 PRM 的 T2DM 易感和耐受巴马小型猪模型的定量蛋白质组学研究。
Gene. 2018 Oct 30;675:119-127. doi: 10.1016/j.gene.2018.06.103. Epub 2018 Jul 2.
9
Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.蛋白质组学发现21种在人血浆来源而非血小板来源的微粒中表达的蛋白质。
Thromb Haemost. 2007 Jan;97(1):67-80.
10
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis.急性血管炎和血液透析期间循环中性粒细胞和血小板微粒增加。
Kidney Int. 2006 Apr;69(8):1416-23. doi: 10.1038/sj.ki.5000306.

引用本文的文献

1
Potential diagnostic markers and therapeutic targets for DM2 and periodontitis based on bioinformatics analysis.基于生物信息学分析的2型糖尿病和牙周炎的潜在诊断标志物及治疗靶点
PLoS One. 2025 Apr 2;20(4):e0320061. doi: 10.1371/journal.pone.0320061. eCollection 2025.
2
Systematic review and bioinformatics analysis of plasma and serum extracellular vesicles proteome in type 2 diabetes.2型糖尿病患者血浆和血清细胞外囊泡蛋白质组的系统评价与生物信息学分析
Heliyon. 2024 Feb 5;10(3):e25537. doi: 10.1016/j.heliyon.2024.e25537. eCollection 2024 Feb 15.
3
The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension.糖尿病与高血压患者循环的大型细胞外囊泡蛋白质组。
Int J Mol Sci. 2023 Mar 3;24(5):4930. doi: 10.3390/ijms24054930.
4
Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches.血小板-中性粒细胞相互作用与糖尿病中的血栓炎症:对新型治疗方法的思考。
J Am Heart Assoc. 2022 Oct 18;11(20):e027071. doi: 10.1161/JAHA.122.027071. Epub 2022 Oct 17.
5
Interplay between Endoplasmic Reticulum Stress and Large Extracellular Vesicles (Microparticles) in Endothelial Cell Dysfunction.内质网应激与大细胞外囊泡(微粒)在内皮细胞功能障碍中的相互作用
Biomedicines. 2020 Oct 12;8(10):409. doi: 10.3390/biomedicines8100409.
6
Coagulatory Defects in Type-1 and Type-2 Diabetes.1 型和 2 型糖尿病的凝血缺陷。
Int J Mol Sci. 2019 Dec 16;20(24):6345. doi: 10.3390/ijms20246345.
7
Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers.代谢综合征中的循环微粒亚群:与氧化应激和凝血标志物的关系。
Diabetes Metab Syndr Obes. 2019 Apr 12;12:485-493. doi: 10.2147/DMSO.S191750. eCollection 2019.
8
Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes.分子机制为糖尿病相关心血管并发症中微粒介导的细胞损伤提供了理论基础。
Oxid Med Cell Longev. 2019 Feb 19;2019:6475187. doi: 10.1155/2019/6475187. eCollection 2019.

本文引用的文献

1
Platelets microparticles as a link between micro- and macro-angiopathy in young patients with type 1 diabetes.血小板微粒作为1型糖尿病年轻患者微血管病变和大血管病变之间的联系。
Platelets. 2015;26(7):682-8. doi: 10.3109/09537104.2015.1018880. Epub 2015 Mar 25.
2
Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status.无论肥胖状况如何,2型糖尿病患者与非2型糖尿病患者的血小板衍生微粒计数及表面分子表达均存在差异。
J Thromb Thrombolysis. 2014 May;37(4):455-63. doi: 10.1007/s11239-013-1000-2.
3
Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients.蛋白质组分析揭示了 2 型糖尿病慢性创面中的抗血管生成环境。
Proteomics. 2013 Sep;13(17):2670-81. doi: 10.1002/pmic.201200502. Epub 2013 Jul 30.
4
The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes.1 型糖尿病患者外周血中炎症基因的表达上调。
Diabetes Care. 2013 Sep;36(9):2794-802. doi: 10.2337/dc12-1986. Epub 2013 May 1.
5
Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop.血浆微粒测定中分析前变量的标准化:国际血栓与止血学会科学和标准化委员会协作研讨会的结果
J Thromb Haemost. 2013 Apr 2. doi: 10.1111/jth.12207.
6
Role of microparticles in sepsis.微粒在脓毒症中的作用。
Br J Anaesth. 2012 Oct;109(4):503-13. doi: 10.1093/bja/aes321. Epub 2012 Sep 4.
7
A role for MRP8 in in stent restenosis in diabetes.MRP8 在糖尿病支架内再狭窄中的作用。
Atherosclerosis. 2012 Apr;221(2):325-32. doi: 10.1016/j.atherosclerosis.2012.01.036. Epub 2012 Feb 1.
8
Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.急性复发性深静脉血栓形成患者循环组织因子阳性微粒。
Thromb Res. 2012 Aug;130(2):253-8. doi: 10.1016/j.thromres.2011.10.014. Epub 2011 Nov 17.
9
Microparticles, vascular function, and atherothrombosis.微粒、血管功能与动脉血栓形成。
Circ Res. 2011 Aug 19;109(5):593-606. doi: 10.1161/CIRCRESAHA.110.233163.
10
Involvement of microparticles in diabetic vascular complications.微粒体在糖尿病血管并发症中的作用。
Thromb Haemost. 2011 Aug;106(2):310-21. doi: 10.1160/TH10-11-0712. Epub 2011 Jun 28.